Protective effect of doxycycline use on coronary artery disease?

Marina Kardara1, Athanasia Papazafiropoulou, Paraskevi Katsakiori

  • 1Health Centre of Erymanthia, School of Medicine, University of Patras, 26500 Rio Patras, Greece.

The Journal of Infection
|September 24, 2005
PubMed

Insights

Doxycycline use may reduce the risk of coronary artery disease (CAD). This study found a significant association between doxycycline and lower CAD occurrence, suggesting potential benefits in cardiovascular health.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Chlamydia pneumoniae infection is increasingly implicated in atherosclerosis.
  • The potential therapeutic role of antibiotics in cardiovascular disease is under investigation.

Purpose of the Study:

  • To investigate if doxycycline, used for brucellosis, reduces coronary artery disease (CAD) risk.
  • To test the hypothesis linking doxycycline treatment to decreased CAD incidence.

Main Methods:

  • Retrospective case-control study using a general practice database in Western Greece.
  • 129 incident CAD cases (2001-2003) compared with 196 controls.
  • Review of medical records for CAD events and cardiovascular risk factors.

Main Results:

  • A significant association was observed between doxycycline use and reduced CAD occurrence (OR: 0.37, 95% CI: 0.17-0.78).
  • This association remained significant after adjusting for confounding factors.

Conclusions:

  • Doxycycline use may be associated with a decreased risk of coronary artery disease.
  • Further epidemiologic studies are warranted to explore this association, particularly regarding Chlamydia pneumoniae infection.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...